Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
12/2014
12/24/2014CN104230961A 一种从长春花中提取长春碱的新方法 A new method of vinblastine extracted from periwinkle
12/24/2014CN104230960A 四并环类间变性淋巴瘤激酶抑制剂 Between four and anaplastic lymphoma kinase inhibitor class ring
12/24/2014CN104230953A 含2-(1,3-二硫/硒-2-亚基)乙氰共轭结构单元的萘二酰亚胺及其衍生物 Containing 2- (1,3-dithiolan / selenium-2-ylidene) acetonitrile conjugated structure units naphthalene diimide and derivatives thereof
12/24/2014CN104230946A 抑制丙肝病毒的化合物、药物组合物及其应用 Compounds inhibit hepatitis C virus, pharmaceutical compositions and use
12/24/2014CN104230935A 含有脂环结构化合物的抗肿瘤作用与应用 Anti-tumor effect and application of compounds containing alicyclic structure
12/24/2014CN104230922A 一类五元杂环并吡啶类化合物及其制备方法和用途 A class of five-membered heterocyclic compounds and pyridine and its preparation and use
12/24/2014CN104230645A 一种蓝色发光材料 One kind of blue light-emitting material
12/23/2014US8916565 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
12/17/2014CN104211923A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211922A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211921A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211920A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211919A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211916A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211915A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211914A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211913A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211912A 共轭聚合物及其制备方法与应用 Conjugated polymer and its preparation method and application
12/17/2014CN104211692A 作为欧若拉激酶抑制剂的衍生物 Aurora kinase inhibitors as derivatives
12/11/2014US20140364429 Antiviral compounds highly effective as hcv-ns5a inhibitor
12/11/2014US20140364414 PDE 10a Inhibitors for the Treatment of Type II Diabetes
12/11/2014US20140364412 Kinase inhibitors
12/11/2014US20140364410 Pyrazolopyrimidine compounds as kinase inhibitors
12/11/2014US20140364392 Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
12/10/2014CN104193971A 一种新型半导体共轭聚合物及其合成方法 A novel semiconductor conjugated polymer and synthetic method
12/10/2014CN104193750A 通过抑制极光激酶抑制有丝分裂的化合物和方法 The compounds and methods of Aurora kinase inhibition by inhibiting mitosis
12/10/2014CN102822170B 作为cFMS抑制剂的取代的N-(1H-吲唑-4-基)咪唑并[1,2-a]吡啶-3-羧酰胺化合物 As cFMS inhibitors substituted N- (1H- indazol-4-yl) imidazo [1,2-a] pyridine-3-carboxamide compound
12/09/2014US8907094 Kinase inhibitors
12/09/2014US8907092 Inhibitors of IAP
12/09/2014US8906852 Inhibitors of protein tyrosine kinase activity
12/04/2014US20140357618 Substituted imidazopyridines as hdm2 inhibitors
12/04/2014US20140356873 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
12/02/2014US8901142 Fused tricyclic compounds as mTOR inhibitors
12/02/2014US8901139 Tricyclic indole derivatives and methods of use thereof
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901126 Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases
11/2014
11/25/2014US8895739 Acylation of hindered amines and functionalized bis-peptides obtained thereby
11/25/2014US8895580 Quinolinone-pyrazolone M1 receptor positive allosteric modulators
11/25/2014US8895572 Fused heterocyclic indane carboxamide CGRP receptor antagonists
11/25/2014US8895543 Vinca derivatives
11/18/2014US8889706 Soluble mTOR complexes and modulators thereof
11/18/2014US8889704 Triazolopyridine compounds as PIM kinase inhibitors
11/18/2014US8889669 Cytotoxic benzodiazepine derivatives
11/18/2014US8889267 Organic light emitting device
11/11/2014US8884032 Trioxane monomers and dimers
11/11/2014US8884027 Melampomagnolide B derivatives as antileukemic and cytotoxic agents
11/11/2014US8884017 2-heteroarylcarboxylic acid amides
11/11/2014US8884005 Method for the preparation of carbapenam compounds
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883775 Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs
11/11/2014US8883771 Bivalent inhibitors of IAP proteins and therapeutic methods using the same
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877756 Substituted pteridines
11/04/2014US8877743 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
10/2014
10/30/2014US20140322739 Methods and compounds for detecting beta-lactamase activity
10/23/2014US20140315885 Therapeutically Active Thiazolo-Pyrimidine Derivatives
10/23/2014US20140315876 Beta-lactamase inhibitors
10/21/2014US8866135 Anthracene derivative and organic electroluminescent element using the same
10/21/2014US8865891 Optically-detectable enzyme substrates and their method of use
10/16/2014US20140309207 Novel spiroindoline compound, and medicinal agent comprising same
10/14/2014US8859822 Synthesis of substituted salicylaldehyde derivatives
10/14/2014US8859774 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
10/14/2014US8859773 N1/N2-lactam acetyl-CoA carboxylase inhibitors
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859538 Uses of substituted imidazoheterocycles
10/14/2014US8859536 Compounds as diacylglycerol acyltransferase inhibitors
10/09/2014WO2014165070A1 Substituted 2-azabicycles and their use as orexin receptor modulators
10/09/2014US20140303366 Certain 1H-Imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-Imidazo[4,5-b]pyrazin-2-ols and Methods for Their Use
10/08/2014EP2786995A1 Azaindoles useful as inhibitors of JAK and other protein kinases
10/07/2014US8853416 Chemical compounds
10/07/2014US8853208 Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
10/02/2014WO2014160692A1 2-keto amide derivatives as hiv attachment inhibitors
10/02/2014WO2014160689A1 Piperazine and homopiperazine derivatives as hiv attachment inhibitors
10/02/2014WO2014159999A1 Cdk9 kinase inhibitors
10/02/2014WO2014159959A1 Inhibitors of human immunodeficiency virus replication
10/02/2014WO2014159591A1 Substituted 7-azabicycles and their use as orexin receptor modulators
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014156342A1 Organic semiconductor material for organic transistor, and organic transistor element
09/2014
09/30/2014US8846925 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
09/30/2014US8846734 Diazonamide analogs
09/25/2014WO2014152725A1 S1p and/or atx modulating agents
09/25/2014US20140288084 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/25/2014US20140288062 Heteroaryl compounds and methods of use thereof
09/25/2014US20140288043 Pyrazolopyridine compounds
09/25/2014US20140287031 Enhanced treatment regimens using mtor inhibitors
09/24/2014EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same
09/24/2014EP2781520A1 Three-ring pi3k and/or mtor inhibitor
09/24/2014EP2781216A1 Chemokine receptor activity regulator
09/24/2014EP2780325A1 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices
09/23/2014US8841456 1,5-naphthyridine derivative or salt thereof
09/23/2014US8841448 Fluoroergoline analogs
09/23/2014US8841289 Heterocyclic derivatives
09/18/2014WO2014143610A1 Pyrrolotriazines as potassium ion channel inhibitors
09/18/2014WO2014140184A1 Novel inhibitor compounds of phosphodiesterase type 10a
09/18/2014US20140275153 Cdk9 kinase inhibitors
09/18/2014US20140275127 Substituted heteroaryl fused derivatives as pi3k inhibitors
09/18/2014US20140275017 Cgrp receptor antagonists
09/17/2014EP2778160A1 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component
09/17/2014EP2776439A1 Purine derivatives for the treatment of viral infections
1 2 3 4 5 6 7 8 9 10 11 12 ... 111